Overexpression of IL13 Rα2 activates the phosphatidylinositol-3 kinase/AKT/mammalian target of rapamycin pathway, leading to poor prognosis and increased tumor invasiveness in GBM (23). Here, IL13RA2 is linked to glioblastoma.